PETER J. ARDUINI is Integra's President and Chief Executive Officer and a director. He joined Integra in November 2010 as President and Chief Operating Officer and was appointed Chief Executive Officer and a director in January 2012. Before joining Integra, Mr. Arduini was Corporate Vice President and President of Medication Delivery, Baxter Healthcare, which he joined in 2005. Mr. Arduini was responsible for a $4.8 billion global division of Baxter focused on inpatient pharmaceuticals and devices. Prior to joining Baxter, Mr. Arduini worked for General Electric Healthcare, where he spent much of his 15 years in a variety of management roles for domestic and global businesses, culminating in leading the global functional imaging business. Prior to joining General Electric Healthcare, he spent four years with Procter and Gamble in sales and marketing. Mr. Arduini serves on the Board of Directors of Bristol-Myers Squibb Company. He serves on the Board of Directors of ADVAMED, the Advanced Medical Technology Association, the Medical Device Innovation Consortium, and the National Italian American Foundation. Mr. Arduini received his bachelor's degree in marketing from Susquehanna University and a master's in management from Northwestern University's Kellogg School of Management.
Kenneth Burhop, PH.D. is Integra's Corporate Vice President, Chief Scientific Officer. Dr. Burhop is responsible for setting Integra's strategic scientific vision and roadmap, as well as leading the Company's portfolio prioritization and management and the scientific evaluation of corporate development and new product opportunities. He joined Integra in February 2014 as Senior Vice President, Chief Scientific Officer and was appointed Corporate Vice President in March 2014. Prior to joining Integra, Dr. Burhop served as Chief Scientific Officer at Sangart, Inc., from January 2011 to October 2013. Prior to joining Sangart, Inc., he spent 24 years with Baxter Healthcare Corporation, from 1986 through 2010, in a series of leadership roles such as Vice President, R&D, Baxter Pharmaceutical Technologies, and Vice President, Global Scientific Lead for Baxter's Medication Delivery Division, a business with over $4 billion in annual sales. Dr. Burhop received his Ph.D. and M.S. in Veterinary Science from the University of Wisconsin-Madison, and his B.A. in Zoology from University of Wisconsin-Milwaukee.
Glenn G. Coleman Corporate Vice President, Chief Financial Officer and Principal Accounting Officer
Glenn G. Coleman is Integra's Corporate Vice President, Chief Financial Officer and Principal Accounting Officer. Mr. Coleman is responsible for the Company's finance department, including accounting and financial reporting, budgeting, internal audit, tax, treasury, investor relations, as well as information technology. He joined Integra in May 2014 as Corporate Vice President, Chief Financial Officer and Principal Accounting Officer, and has 25 years in financial management positions with leading global businesses. Prior to joining the Company, from 2008 to May 2014, Mr. Coleman served as Vice President Finance, Corporate Controller at Curtiss-Wright Corporation, a $2.5 billion global company headquartered in Charlotte, North Carolina that delivers highly-engineered, critical function products and services to the commercial, industrial, defense and energy markets. Prior to joining Curtiss-Wright in 2008, Mr. Coleman worked at Alcatel-Lucent from 1997 to 2007, in various finance executive leadership positions, including Vice President for the Wireless and Wireline Business Groups, Controller for the Americas region, Vice President of Internal Audit and Finance Director of External and Internal Reporting. Mr. Coleman was also instrumental in several significant corporate strategic projects at Alcatel-Lucent, including a multi-billion restructuring program, spin-off of an $8 billion publicly traded entity, and numerous acquisitions. Prior to that, Mr. Coleman began his career at PricewaterhouseCoopers LLP where he was the lead Senior Manager for a top global account. Mr. Coleman received his B.S. degree from Montclair State University and has also been a CPA in New Jersey for more than 20 years.
William Compton is Integra’s Senior Vice President, Chief Information Officer. Mr. Compton is responsible for the Company’s global Information Technology strategy including enterprise applications, infrastructure, information security and business analytics. Mr. Compton has more than 20 years of experience in information systems, systems integration and implementations. Mr. Compton joined Integra in February 2013. Prior to Integra, Mr. Compton was Chief Information Officer and Vice President of Shared Services at ConvaTec for five years. Prior to ConvaTec, Mr. Compton spent 10 years with Bristol Myers-Squibb and several years in consulting. Mr. Compton received a B.S. in Business Administration, an M.I.S. from East Carolina University and an M.B.A. from The College of William and Mary.
Robert T. Davis, Jr. is Integra's Corporate Vice President, and President of Orthopedics and Tissue Technologies. Mr. Davis is responsible for the management of the Orthopedics and Tissue Technologies global division, which includes the orthopedic extremity implants, and regenerative tissue products. His responsibilities include leadership of sales, commercial operations, marketing and strategy, product development, regulatory affairs, quality assurance, manufacturing, services and repair, and business development, worldwide. He joined Integra in July 2012 as president of the Global Neurosurgery business. He was appointed Integra’s corporate vice president in December 2012 and president of the global Specialty Surgical Solutions (SSS) division in 2014 with the integration of Integra’s Neurosurgery and Instruments businesses.
Under his leadership, SSS achieved 12.2% revenue growth. He lead two very successful acquisitions and integrations which resulted in revenue increases of 35.8% and 32.2% respectively. Mr. Davis also has a proven track record in building high performance teams. During his tenure with SSS, he brought on four new leaders at the vice presidential level and decreased turnover by 23% with a 94% retention rate. Prior to joining Integra, Mr. Davis was the General Manager for the Global Anesthesia & Critical Care business at Baxter Healthcare from 2009 to 2012 and held various general management positions at GE Healthcare in the areas of interventional therapeutics, cardiovascular imaging and diagnostic ultrasound from 1997 to 2009. He brings more than 25 years of executive management experience in the global healthcare industry.
Mr. Davis earned his M.B.A. from Drexel University, a Master’s degree in Exercise & Cardiovascular Physiology from Temple University and a B.S. in Sports Medicine from the University of Delaware.
Lisa Evoli Corporate Vice President, Chief Human Resources Officer
LISA EVOLI is Integra's Corporate Vice President, Chief Human Resources Officer. Ms. Evoli is responsible for providing leadership in developing and executing human resources strategy in support of the overall business plan and strategic direction of the organization. She joined Integra as Corporate Vice President, Chief Human Resources Officer in January 2016. Ms. Evoli brings significant global Human Resources leadership experience. Prior to joining Integra, she served as Vice President, Human Resources for the Data & Devices division of TE Connectivity (formerly Tyco Electronics) from September 2012 through December 2015. Prior to working for TE Connectivity, Ms. Evoli held senior global human resources leadership positions with Johnson & Johnson from 2004 through December 2011 in both the Pharmaceutical and Consumer sectors. She held various global human resources leadership roles at Motorola specifically in their Broadband Communications and Automotive groups from 1997 through 2004, and again in April 2011 through August 2012 serving in a Talent Management & Organizational Development leadership role. Ms. Evoli received her B.S. in Business Administration from California University of Pennsylvania and an M.S. in Human Resources / Organizational Development from Villanova University.
Paul Gonsalves is Integra’s Chief Commercial Officer. As Chief Commercial Officer, Mr. Gonsalves is responsible for the Company’s broader commercial strategy and the related infrastructure to drive customer growth and satisfaction, including Corporate Marketing, Corporate Communications, Global Customer Service, Commercial Master Data Management, Government Sales, Enterprise Sales and the Enterprise Sales Operations group. Mr. Gonsalves joined Integra in June 2013 as Senior Vice President of Enterprise Sales & Head of Corporate Marketing and was appointed as Chief Commercial Officer in January 2016. Prior to Integra, Mr. Gonsalves worked with Accent Care Home Health & Hospice as Senior Vice President & Chief Transformation Officer from 2012 to 2013. Prior to joining AccentCare, Mr. Gonsalves was the Vice President & General Manager for Novartis Pharmaceuticals Corporation Primary Care business unit from 2010 to 2012. Prior to Novartis, Mr. Gonsalves worked as Vice President of Business Process Improvement at WellCare Health Plans (HMO) from 2007 to 2010. Starting in 1996, Mr. Gonsalves worked for more than a decade with GE Healthcare starting as a global marketing manager for Computed Tomography and ending as a Vice President & General Manager. Mr. Gonsalves was an early Lean Six Sigma leader at GE Healthcare during Jack Welch’s mandate to become a quality-focused company. Mr. Gonsalves received a B.S.in Management from Rutgers University School of Business.
Richard D. Gorelick is Integra's Corporate Vice President, General Counsel, Administration and Secretary.
Mr. Gorelick was appointed Integra's Corporate Vice President in December 2012. He joined Integra as Vice President
and General Counsel in 2000, and was appointed Senior Vice President and Corporate Secretary in 2006. Mr. Gorelick
also chaired the Human Resources Department from 2008 to 2011. In September 2011, Mr. Gorelick was given the additional
responsibilities of Corporate Communications, Environmental, Health and Safety, Sustainability, Government Relations
and Public Policy, Risk Management, and the Integra Foundation. Prior to joining Integra, he spent four and a half
years at Aventis Behring LLC, a global leader in biologics (plasma proteins) as Associate General Counsel, where his
practice focused on technology licensing, strategic alliances, acquisitions and managing commercial litigation. Prior
to that, Mr. Gorelick worked in the Business and Finance Section of Morgan, Lewis & Bockius LLP, in Philadelphia,
where his practice concentrated on transactions, corporate reorganizations, creditors' rights and secured transactions.
Mr. Gorelick is a graduate of Princeton University and the University of California at Berkeley Law School.
Corporate Vice President, Global Operations and Supply Chain
John Mooradian is Integra's Corporate Vice President, Global Operations and Supply Chain. His responsibilities include global
manufacturing and supply chain. Mr. Mooradian was appointed Integra's Corporate Vice President in December 2012. He joined Integra
in September 2012 as Senior Vice President, Global Operations and Supply Chain. Before coming to Integra, Mr. Mooradian spent 24 years
at Abbott Laboratories in a series of leadership roles, including managing the Hematology and Point of Care businesses and, more recently,
worldwide operations at Abbott Diagnostics Division, a $4 billion business with over 11,000 employees. Prior to Abbott, Mr. Mooradian
held several positions at General Motors. Mr. Mooradian received a B.B.A. degree in Management from the University of Texas, Arlington.
Judith E. O'Grady is Integra's Corporate Vice President, Global Regulatory Affairs.
She was appointed Integra's Corporate Vice President in December 2012. In addition, Ms. O'Grady was Corporate Vice President, Global Regulatory Affairs and Corporate Compliance Officer, from December 2012 to June 2014, Senior Vice President of Regulatory Affairs, and Corporate Compliance Officer, from September 2012 to December 2012, and Senior Vice President, Regulatory Affairs, Quality Assurance, and Corporate Compliance Officer, from 2007 to September 2012. Previously, she was Vice President of Regulatory Affairs, Quality Assurance and Clinical Affairs. Ms. O'Grady has worked in the areas of medical technology and collagen technology for over 25 years. Prior to joining Integra, Ms. O'Grady worked for Colla-Tec, Inc., a Marion Merrell Dow Company. During her career she has held positions with Surgikos, a Johnson & Johnson Company, and was on the faculty of Boston University College of Nursing and Medical School. Ms. O'Grady led the team that obtained the approval of the Food and Drug Administration ("FDA") for INTEGRA® Dermal Regeneration Template, the first regenerative product approved by the FDA, and has led teams responsible for approvals of the Company's other regenerative product lines as well as more than 600 FDA and international submissions. Ms. O'Grady received a B.S. degree from Marquette University and M.S.N. in Nursing from Boston University.
Ms. Platsis is Integra’s Senior Vice President of Corporate Development. Ms. Platsis joined Integra in September 2003 as Director of Corporate Development, and was promoted to Vice President in May 2006 and Senior Vice President in 2011. Ms. Platsis’ responsibilities include the identification and execution of acquisitions and strategic alliances. Prior to joining Integra, Ms. Platsis worked in the investment banking group at Merrill Lynch and practiced law in the Corporate Departments of Latham & Watkins and GoodSmith, Gregg & Unruh. Ms. Platsis received a B.A. in Economics from the University of Michigan, a J.D. from the University of Michigan Law School and an M.B.A from the University of Chicago.
Corporate Vice President and President, Specialty Surgical Solutions
Dan Reuvers is Integra's corporate vice president and president, Specialty Surgical Solutions. The Specialty Surgical Solutions division is a market leader in providing neurosurgical and other surgical solutions, including Integra's CUSA® tissue ablation system, Mayfield® cranial stabilization system, DuraGen® and DuraSeal® dural repair products and many other lifesaving surgical instruments and products.
Prior to being named president of the Surgical Solutions Division in late 2016, Reuvers led the significant growth of Integra's international businesses in Europe, Middle East, Africa, Latin America, Asia Pacific and Canada from 2013 through 2016. Under his leadership, the business expanded its direct sales positions in Italy, UK and broader EU. Presence was also established in China, Japan, Brazil and Mexico and the Middle East during his tenure.
Reuvers was president of Omni-Tract Surgical from 2005 until leading the sale to Integra in 2008. He has since held various positions, including vice president of Marketing and Product Development, president of the acute surgical business, president, Instruments and corporate vice president and president, International. Prior to that, he was president of Advanced Respiratory, Inc. from 2002 to 2004, before leading its sale to Hill-Rom.
Reuvers has more than 25 years of experience in the medical technology field and held various executive level positions in sales, marketing and general management.
He serves on the board of directors of Respirtech, Inc.
Joseph Vinhais is Integra's Corporate Vice President, Global Quality Assurance. His responsibilities include
strategic direction for corporate compliance and quality systems. Mr. Vinhais joined Integra in September 2012
as Senior Vice President, Global Quality Assurance, and was appointed Corporate Vice President in December 2012.
Mr. Vinhais has over 20 years of global quality experience in quality assurance, regulatory affairs, compliance,
and operations execution. Prior to joining Integra, Mr. Vinhais was head of Quality Assurance, Regulatory Affairs,
and Sustainability at Philips Healthcare Imaging Systems, from 2009 to September 2012, where he was responsible
for quality assurance and regulatory affairs for the Computed Tomography and Nuclear Medicine business. Prior to
Philips, Mr. Vinhais was General Manager of Quality Assurance & Regulatory Affairs at General Electric Healthcare,
from 2007 to 2009. Mr. Vinhais received a B.S. in Information Sciences and Systems from Central Connecticut State
University, a certificate in Medical Device Management from Worcester Polytechnic Institute, and a certificate in
Regulatory Affairs and Compliance from Northeastern University.